[go: up one dir, main page]

BRPI0418098A - formulações veterinárias não contendo produtos animais - Google Patents

formulações veterinárias não contendo produtos animais

Info

Publication number
BRPI0418098A
BRPI0418098A BRPI0418098-4A BRPI0418098A BRPI0418098A BR PI0418098 A BRPI0418098 A BR PI0418098A BR PI0418098 A BRPI0418098 A BR PI0418098A BR PI0418098 A BRPI0418098 A BR PI0418098A
Authority
BR
Brazil
Prior art keywords
animal products
animal
veterinary formulations
binder
containing animal
Prior art date
Application number
BRPI0418098-4A
Other languages
English (en)
Inventor
Douglas Cleverly
Michelle Hagenbuch
Jun Chen
Abul Azad
James Muhitch
Wen-Hsia Chen
Hassan Nached
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of BRPI0418098A publication Critical patent/BRPI0418098A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

"FORMULAçõES VETERINáRIAS NãO CONTENDO PRODUTOS ANIMAIS". Esta invenção fornece uma formulação veterinária mastigável, que não contém produtos animais, que compreende: - uma quantidade eficaz de um agente farmaceuticamente ativo que compreende: a) pelo menos um ácido de nodulisporamida ou derivado do ácido nodulispórico; ou b) uma combinação compreendendo i) pelo menos um derivado de avermectina ou milbemicina; e ii) pelo menos um composto selecionado do grupo que consiste em praziquantel e pirantel; - pelo menos um aglutinante; - pelo menos um desintegrador; - pelo menos um aroma não contendo produtos animais ou um aroma derivado de uma fonte não animal; - pelo menos um aglutinante; - pelo menos um umectante; - pelo menos um solvente granulante; e - opcionalmente, pelo menos um antioxidante, pelo menos um agente tamponante, pelo menos um conservante, ou pelo menos um corante.
BRPI0418098-4A 2003-12-23 2004-12-17 formulações veterinárias não contendo produtos animais BRPI0418098A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/745,784 US20040151759A1 (en) 2002-08-16 2003-12-23 Non-animal product containing veterinary formulations
PCT/US2004/042380 WO2005062782A2 (en) 2003-12-23 2004-12-17 Non-animal product containing veterinary formulations

Publications (1)

Publication Number Publication Date
BRPI0418098A true BRPI0418098A (pt) 2007-04-17

Family

ID=34739059

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0418098-4A BRPI0418098A (pt) 2003-12-23 2004-12-17 formulações veterinárias não contendo produtos animais

Country Status (9)

Country Link
US (1) US20040151759A1 (pt)
EP (1) EP1702056A4 (pt)
JP (1) JP2007516285A (pt)
KR (1) KR20060126728A (pt)
CN (1) CN1972672A (pt)
AU (1) AU2004308284A1 (pt)
BR (1) BRPI0418098A (pt)
CR (1) CR8480A (pt)
WO (1) WO2005062782A2 (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060205681A1 (en) * 2002-06-21 2006-09-14 Maryam Moaddeb Homogenous paste formulations
US7976884B2 (en) * 2003-08-01 2011-07-12 Nestec Ltd. Edible animal chew toy
NZ529177A (en) * 2003-10-24 2005-12-23 Agres Ltd Administration process for a delivery device that releases the active agent over several days
WO2006036624A2 (en) * 2004-09-24 2006-04-06 The Hartz Mountain Corporation Lipid stabilized formulations
JP4297042B2 (ja) * 2004-11-30 2009-07-15 ブラザー工業株式会社 シート材収納カセット及びそれを備える画像形成装置
US7955632B2 (en) 2005-12-07 2011-06-07 Bayer B.V. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
AU2006100657C4 (en) * 2006-05-15 2009-09-10 Wyeth Stabilised formulation
JP5475443B2 (ja) * 2006-06-28 2014-04-16 エミスフェアー・テクノロジーズ・インク 硝酸ガリウム製剤
WO2008077130A2 (en) * 2006-12-19 2008-06-26 Merial Limited Homogeneous paste and gel formulations
NZ552290A (en) * 2006-12-21 2009-05-31 Bomac Research Ltd Tablet fomulation
WO2009062939A1 (en) 2007-11-15 2009-05-22 Novartis Ag Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener
FR2924944A1 (fr) * 2007-12-18 2009-06-19 Galderma Sa Composition a base d'une avermectine et du soufre ou d'un derive du soufre, notamment pour le traitement de la rosacee
AU2008360070B2 (en) * 2008-07-29 2015-04-30 Bomac Research Limited Tablet manufacturing method
AR079409A1 (es) * 2009-09-07 2012-01-25 Mukhopadhyay Debashis Preparaciones antihelminticas granuladas y sistemas de suninistros
AU2011315555B2 (en) * 2010-10-12 2016-03-10 Elanco Animal Health Gmbh Non-starch based soft chewables
DK2755498T3 (en) * 2011-09-15 2018-05-22 Friulchem Spa COMPOSITION FOR ORAL ADMINISTRATION FOR ANIMALS AND PROCEDURE FOR OBTAINING
EP2594258B1 (en) * 2011-11-18 2020-03-18 Veterinärmedizinische Universität Wien Oral gel comprising praziquantel
CN110251509A (zh) 2012-02-06 2019-09-20 勃林格殷格翰动物保健美国公司 包含全身性地起作用的活性剂的杀寄生虫口服兽用组合物、方法及其用途
CN104203214B (zh) 2012-04-04 2018-05-25 英特维特国际股份有限公司 软咀嚼药用产品
KR101348687B1 (ko) * 2012-05-03 2014-01-16 남원모 사료첨가용 은나노 조성물
CA2883139C (fr) 2012-08-31 2021-08-10 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
CN105451771B (zh) 2013-03-15 2020-05-19 阿根塔创新有限公司 可咀嚼配制物
CN103993061B (zh) * 2014-05-20 2018-03-23 海南美合泰生物科技有限公司 一种鱼胶原蛋白的生产方法
BR112017024773A2 (pt) 2015-05-20 2018-11-06 Merial, Inc. compostos depsipeptídeos anti-helmínticos
US9808010B2 (en) 2015-07-06 2017-11-07 Virbac Corporation Chewable composition
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
EP3496714A4 (en) 2016-08-11 2020-04-22 Adamis Pharmaceuticals Corporation DRUG COMPOSITIONS.
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
BR112019009977A2 (pt) 2016-11-16 2019-08-27 Boehringer Ingelheim Animal Health Usa Inc compostos depsipeptídicos anti-helmínticos
RU2764849C2 (ru) * 2016-12-09 2022-01-21 Байер Энимэл Хельс ГмбХ Фармацевтический препарат и способ его получения
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation MEDICINAL COMPOSITIONS
KR20250044476A (ko) 2018-07-09 2025-03-31 베링거잉겔하임베트메디카게엠베하 구충성 헤테로시클릭 화합물
CN113260419A (zh) 2018-11-20 2021-08-13 勃林格殷格翰动物保健美国公司 吲唑基氰基乙基氨基化合物、其组合物、其制备方法和其使用方法
KR20220002890A (ko) 2019-03-19 2022-01-07 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 구충성 아자-벤조티오펜 및 아자-벤조푸란 화합물
TW202122077A (zh) * 2019-09-06 2021-06-16 美商拜耳保健責任有限公司 適口軟咀嚼物
CN113134008B (zh) * 2020-01-17 2022-08-30 中国农业大学 宠物用伊维菌素吡喹酮咀嚼片及其制备方法
KR20230028268A (ko) 2020-05-29 2023-02-28 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 구충성 헤테로시클릭 화합물
CA3191346A1 (en) * 2020-09-03 2022-03-10 Clement Maxime Chevreau Chewable formulations
CA3191671A1 (en) 2020-09-04 2022-03-10 Elanco Us Inc. Palatable formulations
US11827657B2 (en) 2020-12-18 2023-11-28 Boehringer Ingelheim Animal Health USA Inc. Boron containing pyrazole compounds, compositions comprising them, methods and uses thereof
WO2023198476A1 (en) 2022-04-15 2023-10-19 Krka, D.D., Novo Mesto Soft chewable veterinary dosage form
CN120361008B (zh) * 2025-04-28 2025-12-09 广州白云山宝神动物保健品有限公司 基于米尔贝肟吡喹酮的寄生虫驱除药物及其应用

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3615728A (en) * 1968-10-11 1971-10-26 Us Agriculture Method for imparting hickory smoke color and flavor to dried yeast and other food powders
US3773525A (en) * 1970-08-31 1973-11-20 A Pittet Flavoring with bicyclic dehydropiperazines
ZA741203B (en) * 1973-03-23 1975-01-29 Smithkline Corp Veterinary feed compositions for inhibiting rumen microbial deamination
NZ247278A (en) * 1991-02-12 1995-03-28 Ancare Distributors Veterinary anthelmintic drench comprising a suspension of praziquantel in a liquid carrier
US5180720A (en) * 1991-05-03 1993-01-19 G. D. Searle & Co. 2- and 3-alkoxy or hydroxy-8-substituted-dibenz[b,f]-[1,4]oxazepine-10(11H)-carboxylic acid, substituted hydrazides and methods for treating pain
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
AU653423B2 (en) * 1991-05-28 1994-09-29 Mcneil-Ppc, Inc. Chewable drug-delivery composition
US5477815A (en) * 1992-08-20 1995-12-26 Booda Products, Inc. Dog chew toy
CA2138812A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivative and processes for preparing the same
EP0745036B1 (en) * 1994-02-16 1998-03-25 Bettacare Limited Infant car seats
US5894029A (en) * 1994-03-21 1999-04-13 Purebred Pet Products, Inc. Method of making pet snack food
EP0760648B1 (en) * 1994-05-20 2001-11-14 Janssen Pharmaceutica N.V. Chewable flubendazole tablets for companion animals
AUPM969994A0 (en) * 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
US5962499A (en) * 1995-03-20 1999-10-05 Merck & Co., Inc. Nodulisporic acid derivatives
US6221894B1 (en) * 1995-03-20 2001-04-24 Merck & Co., Inc. Nodulisporic acid derivatives
US5747058A (en) * 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
IN182040B (pt) * 1995-06-13 1998-12-12 American Home Prod
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5958888A (en) * 1996-07-02 1999-09-28 Merial, Inc. Water miscible macrolide solutions
US6110521A (en) * 1996-10-25 2000-08-29 T.F.H. Publications, Inc. Wheat and casein dog chew with modifiable texture
US5827565A (en) * 1996-10-25 1998-10-27 T.F.H. Publications, Inc. Process for making an edible dog chew
US6086940A (en) * 1996-10-25 2000-07-11 T.F.H. Publications, Inc. High starch content dog chew
US6093427A (en) * 1997-09-03 2000-07-25 T.F.H.Publications, Inc. Vegetable-based dog chew
US6200616B1 (en) * 1996-10-25 2001-03-13 Tfh Publications, Inc. Animal chew
US6126978A (en) * 1996-10-25 2000-10-03 T.F.H. Publications, Inc. Edible dog chew
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
US6093441A (en) * 1998-07-15 2000-07-25 Tfh Publications, Inc. Heat modifiable peanut dog chew
US6174540B1 (en) * 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
US6159516A (en) * 1999-01-08 2000-12-12 Tfh Publication, Inc. Method of molding edible starch
US6274182B1 (en) * 1999-11-19 2001-08-14 Tfh Publications, Inc. Animal chew
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
US6207179B1 (en) * 2000-05-18 2001-03-27 Phoenix Scientific, Inc. Parasiticidal formulation for animals and a method of making this formulation
US6399786B1 (en) * 2000-07-14 2002-06-04 Merck & Co., Inc. Nonacyclic nodulisporic acid derivatives
DK1197215T3 (da) * 2000-10-10 2006-07-10 Wyeth Corp Anthelmintiske sammensætninger
EP1247456A3 (en) * 2001-02-28 2003-12-10 Pfizer Products Inc. Palatable pharmaceutical compositions for companion animals
US6787642B2 (en) * 2001-03-23 2004-09-07 The Regents Of The University Of California Use of insect cell membrane transporters as novel target sites for inspection
US20030064941A1 (en) * 2001-05-21 2003-04-03 Pfizer Inc. Avermectin and praziquantel combination therapy
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals

Also Published As

Publication number Publication date
EP1702056A4 (en) 2012-05-02
JP2007516285A (ja) 2007-06-21
US20040151759A1 (en) 2004-08-05
AU2004308284A1 (en) 2005-07-14
CN1972672A (zh) 2007-05-30
WO2005062782A3 (en) 2006-08-10
CR8480A (es) 2007-04-24
WO2005062782A2 (en) 2005-07-14
KR20060126728A (ko) 2006-12-08
EP1702056A2 (en) 2006-09-20

Similar Documents

Publication Publication Date Title
BRPI0418098A (pt) formulações veterinárias não contendo produtos animais
BR0313528A (pt) Formulações veterinárias contendo produto não-animal
BR9808581A (pt) Estabilização de benzimidazóis sensìveis a ácido com combinações de aminoácido/ciclodextrina
DK1299108T3 (da) Parasiticidt præparat samt fremgangsmåde til fremstilling af dette præparat
BRPI0819849B8 (pt) sistemas de solvente para formulações pour on para combater parasitas
ATE300283T1 (de) Propofol-formulierung
BR0318319A (pt) métodos de preparação e formulações/composições sustentadas pelo uso de dimeticona como veìculo
BRPI0409185A (pt) formulações veterinárias anti-helmìnticas tópicas
EA200100458A1 (ru) Антипаразитарные препараты
BR0215421A (pt) Processo para a preparação de um sistema de distribuição de ingrediente ou composição hidrófoba granular, e, sistema de distribuição granular
PT1246809E (pt) Compostos de 5-aril-1h-1,2,4-triazole como inibidores de ciclooxigenase-2 e composicoes farmaceuticas que os contem
ATE287707T1 (de) Injizierbare propofol-formulierungen
AU2008282388A1 (en) Endoparasiticidal topical compositions
CY1107789T1 (el) Ανθελμινθικαι συνθεσεις περιεχουσαι συνδυασμους αβερμεκτινων ή μιλβεμυκινων μετα δις-αρυλο ενωσεων
PT1073467E (pt) Formulacoes de co-solvente que compreendem um composo de vitamina d.
BR9202771A (pt) Composicao em microesfera e processos para proteger ou tratar animais de sangue quente,para introduzir e manter niveis no sangue de um composto e para preparar composicoes em microesfera
CA2364742A1 (en) Anthelmintic composition
TNSN07285A1 (en) Anthelmintic composition
ES2194279T3 (es) Composiciones de ciclodextrina que contienen un derivado de avermectina o de milbemicina.
BR0013283A (pt) Agente farmacêutico que compreende um derivado de benzamida como ingrediente ativo
WO2008077130A3 (en) Homogeneous paste and gel formulations
EP1136080A3 (en) Use of o-vanillin and o-vanillin/trolox combinations
ATE207492T1 (de) Difluoroavermectin-derivate
EA200500671A1 (ru) Фармацевтический состав оланзапина
KR20200050565A (ko) 셀라멕틴을 포함하는 구충제 조성물

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: MERIAL, INC. (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]